Latest Patents News

Page 19 of 104
Entropy Neurodynamics has expanded its global intellectual property portfolio with a South African patent for psilocybin-based fibromyalgia treatment, covering broad therapeutic methods and extending protection to 2043.
Ada Torres
Ada Torres
20 July 2026
Hazer Group has completed a key commercial-scale hydrogen process design package with KBR, boosting its readiness for large-scale deployment and expanding its project pipeline across multiple sectors and geographies.
Maxwell Dee
Maxwell Dee
20 July 2026
Dimerix has acquired DMX-652, a Phase 2-ready oral drug candidate targeting acute kidney injury, expanding its renal disease portfolio. The acquisition includes patent rights, an FDA-approved trial protocol, and funding to initiate clinical development.
Ada Torres
Ada Torres
17 July 2026
Titomic Limited updates investors that its planned shift of corporate domicile from Australia to the US is still underway but the timeline has slipped, with a revised schedule expected by late July or August 2026.
Victor Sage
Victor Sage
16 July 2026
Neurotech International has locked in a $3.15 million secured loan against its anticipated R&D tax incentives to fund pivotal Phase III autism trials and ongoing operations.
Ada Torres
Ada Torres
15 July 2026
Phoslock Environmental Technologies increased production significantly in the June quarter but faced a higher operating cash flow deficit and ongoing legal disputes.
Maxwell Dee
Maxwell Dee
15 July 2026
Advanced Engineered Materials has locked in an exclusive supply agreement with Swiss manufacturer Zürcher Frères, leveraging its nano particle high purity alumina to significantly enhance zirconia-alumina ceramics used in medical and industrial applications.
Maxwell Dee
Maxwell Dee
15 July 2026
Starpharma launches a fully underwritten $32 million entitlement offer to fund the Phase 1 trial of its DEP® HER2-Lutetium radiopharmaceutical and accelerate its targeted oncology asset development.
Ada Torres
Ada Torres
15 July 2026
Mesoblast has completed treatment of 300 patients in its pivotal Phase 3 trial for rexlemestrocel-L, targeting chronic low back pain due to degenerative disc disease, with topline results expected mid-2027.
Ada Torres
Ada Torres
14 July 2026
Impact Minerals (ASX:IPT) has received a $310,000 Research and Development tax rebate for FY2025, supporting its Lake Hope High Purity Alumina project and investment in Alluminous Pty Ltd.
Maxwell Dee
Maxwell Dee
14 July 2026
Recce Pharmaceuticals has expanded its intellectual property footprint with a key patent granted in Vietnam for its RECCE® anti-infective drugs, reinforcing its presence in a critical Southeast Asian market grappling with high antibiotic resistance.
Victor Sage
Victor Sage
14 July 2026
Neurotech International has secured FDA clearance for its Investigational New Drug application for NTI164, enabling clinical development in the US and advancing its global registration and commercialisation plans.
Ada Torres
Ada Torres
14 July 2026

Browse the archive

Full archive